DK409384A - Krystallinsk salt af en l- eller (s)-3-(3,4-dihydroxyphenyl)-2-methylalaninester og fremgangsmaade til fremstilling deraf - Google Patents

Krystallinsk salt af en l- eller (s)-3-(3,4-dihydroxyphenyl)-2-methylalaninester og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK409384A
DK409384A DK409384A DK409384A DK409384A DK 409384 A DK409384 A DK 409384A DK 409384 A DK409384 A DK 409384A DK 409384 A DK409384 A DK 409384A DK 409384 A DK409384 A DK 409384A
Authority
DK
Denmark
Prior art keywords
methylalanine
dihydroxyphenyl
salts
crystallinic
estes
Prior art date
Application number
DK409384A
Other languages
Danish (da)
English (en)
Other versions
DK409384D0 (da
Inventor
John Budavari
Robert F Czaja
Edward J J Grabowski
William F Shukis
Arthur J Zambito
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK409384D0 publication Critical patent/DK409384D0/da
Publication of DK409384A publication Critical patent/DK409384A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK409384A 1983-08-29 1984-08-28 Krystallinsk salt af en l- eller (s)-3-(3,4-dihydroxyphenyl)-2-methylalaninester og fremgangsmaade til fremstilling deraf DK409384A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52752683A 1983-08-29 1983-08-29

Publications (2)

Publication Number Publication Date
DK409384D0 DK409384D0 (da) 1984-08-28
DK409384A true DK409384A (da) 1985-03-01

Family

ID=24101812

Family Applications (1)

Application Number Title Priority Date Filing Date
DK409384A DK409384A (da) 1983-08-29 1984-08-28 Krystallinsk salt af en l- eller (s)-3-(3,4-dihydroxyphenyl)-2-methylalaninester og fremgangsmaade til fremstilling deraf

Country Status (14)

Country Link
EP (1) EP0139983B1 (ja)
JP (1) JPS6072848A (ja)
KR (1) KR900003530B1 (ja)
AT (1) ATE30318T1 (ja)
AU (1) AU575067B2 (ja)
CA (1) CA1232614A (ja)
DE (1) DE3466877D1 (ja)
DK (1) DK409384A (ja)
ES (1) ES8700226A1 (ja)
GR (1) GR80155B (ja)
IL (1) IL72726A (ja)
NZ (1) NZ209285A (ja)
PT (1) PT79107B (ja)
ZA (1) ZA846698B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4781352B2 (ja) * 2004-06-04 2011-09-28 ゼノポート,インコーポレーテッド レボドパプロドラッグおよびその組成物ならびにその使用
CA2673336A1 (en) * 2006-12-21 2008-06-26 Xenoport, Inc. Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983138A (en) * 1973-09-25 1976-09-28 Merck & Co., Inc. Amino acid esters
US4404392A (en) * 1981-11-16 1983-09-13 Merck & Co., Inc. Resolution of α-pivaloyloxyethyl-(S)-3-(3,4-dihydroxyphenyl)-2-methylalantinate into its α and β isomers
US4440942A (en) * 1982-03-01 1984-04-03 Merck & Co., Inc. Crystalline diastereomeric L-alpha-methyldopa POE ester and process for its preparation

Also Published As

Publication number Publication date
ATE30318T1 (de) 1987-11-15
GR80155B (en) 1984-12-19
EP0139983B1 (en) 1987-10-21
JPS6072848A (ja) 1985-04-24
AU575067B2 (en) 1988-07-21
EP0139983A1 (en) 1985-05-08
ES535444A0 (es) 1986-10-16
AU3244884A (en) 1985-03-07
PT79107A (en) 1984-09-01
CA1232614A (en) 1988-02-09
ZA846698B (en) 1986-04-30
NZ209285A (en) 1988-04-29
PT79107B (en) 1986-11-14
IL72726A (en) 1988-02-29
KR900003530B1 (ko) 1990-05-21
DE3466877D1 (en) 1987-11-26
ES8700226A1 (es) 1986-10-16
IL72726A0 (en) 1984-11-30
DK409384D0 (da) 1984-08-28
KR850001729A (ko) 1985-04-01

Similar Documents

Publication Publication Date Title
DK462480A (da) Fremgangsmaade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenaminderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK462380A (da) Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf
DK164450C (da) Alkylsulfonamidophenylalkylaminer eller syreadditionssalte deraf, farmaceutiske formuleringer indeholdende saadanne forbindelser og fremgangsmaade til fremstilling af forbindelserne
DK65987D0 (da) 1,4-benzoxazinderivater eller syreadditionssalte deraf, fremgangsmaade til fremstilling af forbindelserne og forbindelsernes anvendelse
DK151017C (da) Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK149336C (da) Fremgangsmaade til fremstilling af antibiotikum a/16686 eller syreadditionssalte deraf
ES508025A0 (es) "procedimiento para preparar derivados de dihidropiridina".
DK142544C (da) Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf
DK134580A (da) Fremgangsmaade til fremstilling af 2,6-diaminonebulariner eller syreadditionssalte deraf
DK157451C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-6-alkoxybenzyl-5-methylpyridooe2,3-daapyrimidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK98383D0 (da) Fremgangsmade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK409384A (da) Krystallinsk salt af en l- eller (s)-3-(3,4-dihydroxyphenyl)-2-methylalaninester og fremgangsmaade til fremstilling deraf
DK161833C (da) Analogifremgangsmaade til fremstilling af n-(vinblastinoyl-23)-derivater af aminosyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK150481C (da) Analogifremgangsmaade til fremstilling af 3',4'-dihydro-spiro-(imidazolidin-4,1'-(2'h)-naphthalen)-5-on eller farmaceutisk acceptable syreadditionssalte deraf
DK398283A (da) Fremgangsmaade til fremstilling af 1,4-dihydropyridinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK193580A (da) Fremgangsmaade til fremstilling af 5-(2-( (2,3-dihydro-1,4-benzodioxan-2-yl-methyl)amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-derivater
DK251480A (da) Fremgangsmaade til fremstilling af 3,3-dimethylcyclopropan-1,1,2-tricarboxylsyrederivater som mellemprodukter anvendelige alfa-halogennitriler og disses fr&mstilling
DK145080A (da) Fremgangsmaade til fremstilling af aminoderivater af 2-hydroxy-6,9-methano-11-amino-5,6,7,8,9,10-hexahydrobenzocycloocten
DK372279A (da) Fremgangsmaade til fremstilling af aminsalte af sure 0,dialkylthiophosphorsyreestere
DK147105C (da) Analogifremgangsmaade til fremstilling af 4,4'-dihydroxy-3,3'-diphenylarylmethandicarboxylsyrer eller farmaceutisk acceptable salte heraf
ES555393A0 (es) Procedimiento para preparar compuestos dimeros de derivados de aminoacidos.
DK413280A (da) Fremgangsmaade til fremstilling af syreadditionssalte af p-hydroxy-n-(1-methyl-3-phenylpropyl)-nor-ephedrin
DK284789A (da) Fremgangsmaade til fremstilling af n-(23-vinblastinoyl)-derivater af 1-aminomethylphosphonsyre
ES557003A0 (es) Procedimiento para preparar compuestos dimeros de derivados de aminoacidos.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment